Onderzoeker
Eline Abma
- Disciplines:Veterinaire farmacologie en toxicologie
Affiliaties
- Vakgroep Kleine Huisdieren (Departement)
Lid
Vanaf12 aug 2013 → 20 sep 2020
Projecten
1 - 1 of 1
- OncoCiDia: een innovatieve, twee-stappen antikankerstrategie - klinisch onderzoek bij honderVanaf1 jan 2015 → 30 nov 2019Financiering: IWT persoonsgebonden financ. - strategische onderzoeksbeurzen, IWT persoonsgebonden financ. - specialisatiebeurzen
Publicaties
1 - 10 van 17
- Assessment of cardiotoxicity after combretastatin A4-phosphate administration in dogs using two-dimensional speckle tracking echocardiography(2022)
Auteurs: Gitte Mampaey, Hilde De Rooster, Eline Abma, Arnaut Hellemans, Tom Schipper, Bart Broeckx, Pascale Smets
Aantal pagina's: 1 - Assessment of cardiotoxicity after a single dose of combretastatin A4-phosphate in dogs using two-dimensional speckle-tracking echocardiography(2022)
Auteurs: Gitte Mampaey, Arnaut Hellemans, Eline Abma, Bart Broeckx, Sylvie Daminet, Pascale Smets
- Fluorescence-guided surgery using indocyanine green in dogs with superficial solid tumours(2020)
Auteurs: Sophie Favril, Eline Abma, Emmelie Stock, Nausikaa Devriendt, Bart Van Goethem, Francesco Blasi, Chiara Brioschi, Ingeborgh Polis, Hilde De Cock, Luigi Miragoli, et al.
- Preliminary safety and imaging efficacy of the near-infrared fluorescent contrast agent DA364 during fluorescence-guided surgery in dogs with spontaneous superficial tumors(2020)
Auteurs: Sophie Favril, Chiara Brioschi, Katrien Vanderperren, Eline Abma, Emmelie Stock, Nausikaa Devriendt, Ingeborgh Polis, Hilde De Cock, Alessia Cordaro, Luigi Miragoli, et al.
Pagina's: 2310 - 2326 - Power Doppler ultrasound and contrast-enhanced ultrasound demonstrate non-invasive tumour vascular response to anti-vascular therapy in canine cancer patients(2019)
Auteurs: Eline Abma, Emmelie Stock, Ward De Spiegelaere, Leen Van Brantegem, Katrien Vanderperren, Yicheng Ni, Matthijs Vynck, Sylvie Daminet, Kaat De Clercq, Hilde De Rooster
- OncoCiDia : an innovative cancer treatment combining a vascular disrupting agent with targeted radiotherapy : preliminary results in dogs(2019)
Auteurs: Eline Abma
- A dose-escalation study of combretastatin A4-phosphate in healthy dogs(2018)
Auteurs: Eline Abma, Pascale Smets, Sylvie Daminet, Ine Cornelis, Kaat De Clercq, Y Ni, Lise Vlerick
Pagina's: E16 - E22 - Biosecurity measures for dog merchants and canine breeding kennels(2018)
Auteurs: Pierre-Alexandre Dendoncker, Eline Abma, Eline Wydooghe, Filip Van Immerseel
Pagina's: 433 - 452 - Biodistribution and tolerance of intravenous iodine-131-labelled hypericin in healthy dogs(2018)
Auteurs: Eline Abma, Kathelijne Peremans, Filip De Vos, Tim Bosmans, Adriaan Kitshoff, Sylvie Daminet, Y Ni
Pagina's: 318 - 323 - A single dose of intravenous combretastatin A4-phosphate is reasonably well tolerated and significantly reduces tumour vascularization in canine spontaneous cancers(2018)
Auteurs: Eline Abma, Ward De Spiegelaere, Katrien Vanderperren, Emmelie Stock, Ine Cornelis, Sylvie Daminet, Y Ni, Glenn Verstraete, Pascale Smets
Pagina's: 467 - 477